thymoquinone has been researched along with Adverse Drug Event in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afrin, T; Alam, M; Choi, HJ; Dash, R; Hannan, MA; Haque, MN; Hossain, MT; Jahan, I; Khan, MK; Kim, B; Mitra, S; Mohibbullah, M; Moon, IS; Munni, YA; Oktaviani, DF; Rahman, MA; Rahman, MM; Rahman, MS; Sarker, PP; Sikder, MH; Sohag, AAM; Tahjib-Ul-Arif, M; Timalsina, B; Uddin, MJ | 1 |
| Cho, DY; Choi, DK; Ezazul Haque, M; Ganesan, P; Jakaria, M; Karthivashan, G; Kim, IS | 1 |
2 review(s) available for thymoquinone and Adverse Drug Event
| Article | Year |
|---|---|
Black Cumin (
Topics: Anti-Inflammatory Agents; Antioxidants; Benzoquinones; Biological Availability; Cell Survival; Dietary Supplements; Drug Delivery Systems; Drug-Related Side Effects and Adverse Reactions; Energy Metabolism; Functional Food; Humans; Immunomodulation; Inflammation; Nigella sativa; Oxidative Stress; Phytotherapy; Plant Preparations | 2021 |
Neuropharmacological Potential and Delivery Prospects of Thymoquinone for Neurological Disorders.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antioxidants; Benzoquinones; Drug Delivery Systems; Drug-Related Side Effects and Adverse Reactions; Humans; Nervous System; Nervous System Diseases; Neuropharmacology; Nigella sativa | 2018 |